| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 162.78B | 157.34B | 140.20B | 161.11B | 123.58B | 112.79B |
| Gross Profit | 16.44B | 16.55B | 15.55B | 16.88B | 13.53B | 11.05B |
| EBITDA | 5.77B | 6.11B | 6.08B | 7.17B | 4.50B | 2.41B |
| Net Income | 3.91B | 3.52B | 2.74B | 3.83B | 2.52B | 1.65B |
Balance Sheet | ||||||
| Total Assets | 80.00B | 84.05B | 78.88B | 78.60B | 72.81B | 84.92B |
| Cash, Cash Equivalents and Short-Term Investments | 8.18B | 9.36B | 8.79B | 8.89B | 9.31B | 25.54B |
| Total Debt | 19.87B | 24.26B | 24.14B | 26.99B | 24.60B | 25.56B |
| Total Liabilities | 40.20B | 43.50B | 40.51B | 44.35B | 42.12B | 41.71B |
| Stockholders Equity | 39.73B | 40.49B | 38.30B | 34.18B | 30.63B | 43.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 678.00M | 5.34B | -869.00M | 2.12B | -1.86B |
| Operating Cash Flow | 0.00 | 3.98B | 5.74B | -780.00M | 2.19B | -1.69B |
| Investing Cash Flow | 0.00 | -2.22B | -364.00M | -46.00M | -149.00M | -380.00M |
| Financing Cash Flow | 0.00 | -1.11B | -5.88B | 262.00M | -18.58B | 8.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥15.60B | 3.06 | ― | 1.23% | 35.89% | 162.00% | |
70 Outperform | ¥14.73B | 37.68 | ― | 3.47% | -14.79% | -41.15% | |
67 Neutral | ¥11.62B | 12.00 | 11.46% | 4.65% | 20.51% | 66.82% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥12.43B | 13.17 | ― | 3.70% | -10.61% | -18.70% | |
56 Neutral | ¥10.13B | 10.86 | ― | 1.86% | -7.54% | ― | |
45 Neutral | ¥19.60B | 15.70 | ― | 3.98% | -6.84% | 50.71% |